{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:37:06Z","timestamp":1763638626645,"version":"3.45.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00731","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:40:27Z","timestamp":1757518827000},"page":"e00731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Talin 1 plays a significant role in the development of tolerogenic dendritic cells, which may contribute to the progression of multiple sclerosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Kouichi","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00731_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0036-1579739","article-title":"Immunology of multiple sclerosis","volume":"36","author":"Sospedra","year":"2016","journal-title":"Semin Neurol"},{"key":"10.1016\/j.neurot.2025.e00731_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WCO.0000000000000205","article-title":"Advances in the immunopathogenesis of multiple sclerosis","volume":"28","author":"Yadav","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurot.2025.e00731_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2023","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.neurot.2025.e00731_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.657768","article-title":"Emerging therapeutics for immune tolerance: tolerogenic vaccines, T cell therapy, and IL-2 therapy","volume":"12","author":"Moorman","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2025.e00731_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4049\/jimmunol.1901121","article-title":"Natural and induced tolerogenic dendritic cells","volume":"204","author":"Iberg","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.neurot.2025.e00731_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","article-title":"Dendritic cells as inducers of peripheral tolerance","volume":"38","author":"Iberg","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.neurot.2025.e00731_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166934","article-title":"Alleviation of experimental autoimmune encephalomyelitis by transferring low RelB expression tolerogenic dendritic cells","volume":"1870","author":"Zheng","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.neurot.2025.e00731_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/intimm\/dxm084","article-title":"IL-10 permits transient activation of dendritic cells to tolerize T cells and protect from central nervous system autoimmune disease","volume":"19","author":"Perona-Wright","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.neurot.2025.e00731_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cellimm.2007.10.006","article-title":"The presence of GM-CSF and IL-4 interferes with effect of TGF-beta1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis","volume":"249","author":"Xiao","year":"2007","journal-title":"Cell Immunol"},{"key":"10.1016\/j.neurot.2025.e00731_bib10","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1096\/fj.201601243R","article-title":"Dendritic cells, engineered to overexpress 25-hydroxyvitamin D 1alpha-hydroxylase and pulsed with a myelin antigen, provide myelin-specific suppression of ongoing experimental allergic encephalomyelitis","volume":"31","author":"Li","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.neurot.2025.e00731_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/imm.12776","article-title":"1,25-dihydroxyvitamin D(3) -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells","volume":"152","author":"Xie","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.neurot.2025.e00731_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrm3624","article-title":"Talins and kindlins: partners in integrin-mediated adhesion","volume":"14","author":"Calderwood","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.neurot.2025.e00731_bib13","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.4049\/jimmunol.2100843","article-title":"Direct binding of Rap1 to Talin1 and to MRL proteins promotes integrin activation in CD4(+) T cells","volume":"208","author":"Lagarrigue","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.neurot.2025.e00731_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191810","article-title":"Talin1 controls dendritic cell activation by regulating TLR complex assembly and signaling","volume":"217","author":"Lim","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurot.2025.e00731_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jneuroim.2017.02.008","article-title":"Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity","volume":"305","author":"Muto","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurot.2025.e00731_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-065X.1998.tb01211.x","article-title":"The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"164","author":"Tuohy","year":"1998","journal-title":"Immunol Rev"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:33:53Z","timestamp":1763638433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925002090"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00731","relation":{},"ISSN":["1878-7479"],"issn-type":[{"type":"print","value":"1878-7479"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Talin 1 plays a significant role in the development of tolerogenic dendritic cells, which may contribute to the progression of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00723","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00731"}}